Myeloid Leukemias Completed Phase 1 / 2 Trials for Gemtuzumab ozogamicin (DB00056)

Back to Myeloid Leukemias

Also known as: Leukemia, Myeloid / Myeloid leukaemia / Myeloid Leukemia / Leukemia myeloid / Non-lymphoblastic leukaemia NOS / Leukemic granulocytic / Non-lymphoblastic leukemia NOS / Unspecified myeloid leukaemia / Unspecified myeloid leukemia / Leukaemia myelogenous / Leukemia myelogenous / Myelocytic leukaemia / Myelocytic leukemia / Leukemia granulocytic NOS / Leukaemia granulocytic NOS / Leukaemia granulocytic / Leukemia granulocytic / Leukaemia myeloid / Myeloid leukemia NOS / Myeloid leukaemia NOS

Indication	Status	Phase
DBCOND0042450 (Myeloid Leukemias)	Completed	1 / 2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00233909	A Trial of Gemtuzumab Ozogamicin (GO) in Combination With Zosuquidar in Patients With CD33 Positive Acute Myeloid Leukemia	Treatment	Gemtuzumab ozogamicin (DB00056) Zosuquidar (DB06191)